Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.279SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.67SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
AD.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.201SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
W.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HD.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FD.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FK.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBF.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GJ.1.2.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.1.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAGSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.9.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.1.4.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DJ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13769.6Singapore
BQ.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.11.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BE.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BY.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.2.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BE.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BN.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BF.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.2.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.1.3.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BQ.1.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
DV.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2 (Omicron)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used